Surveillance of glaucoma medical therapy in a Glasgow teaching hospital: 26 Years' experience

British Journal of Ophthalmology

Volumn 93, Issue 12, 2009, Pages 1572-1575

  Rahman, M Q ^a   Montgomery, D M I ^b   Lazaridou, M N ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BIMATOPROST; BIMATOPROST PLUS TIMOLOL; BRIMONIDINE; BRIMONIDINE PLUS TIMOLOL; BRINZOLAMIDE; DIPIVEFRINE; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; LATANOPROST PLUS TIMOLOL; LEVOBUNOLOL; PILOCARPINE; TIMOLOL; TIMOLOL MALEATE; TIMOLOL PLUS TRAVOPROST; TRAVOPROST;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CLINICAL PROTOCOL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PRESCRIPTION; PRIORITY JOURNAL; TEACHING HOSPITAL; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

AGED; ALGORITHMS; ANTIHYPERTENSIVE AGENTS; CLINICAL PROTOCOLS; DATABASES, FACTUAL; DRUG UTILIZATION; FEMALE; GLAUCOMA; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; OCULAR HYPERTENSION; OUTPATIENT CLINICS, HOSPITAL; SCOTLAND;

EID: 72449206593     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.151522     Document Type: Article

References (12)

1. Read RM, Spaeth GL. The practical clinical appraisal of the optic disc in glaucoma: the natural history of cup progression and some specific disc-field. Trans Am Acad Ophthalmol Otolaryngol 1974;78:OP255-74.
2. Knox FA, Barry M, McGowan B, et al. The rising cost of glaucoma drugs in Ireland 1996-2003. Br J Ophthalmol 2006;90:162-165
3. Bateman DN, Clark R, Azuara-Blanco A, et al. The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care. Br J Ophthalmol 2002;86:551-554 (Pubitemid 34454502)
4. Stein JD, Sloan FA, Lee PP. Rates of glaucoma medication utilization among older adults with suspected glaucoma, 1992 to 2002. Am J Ophthalmol 2007;143:870-872
5. IMS-Health. S01E2 Market/Xalatan. Combined retail and hospital sales 2008 (June).
6. Zhou Z, Althin R, Sforzolini BS, et al. Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom. Br J Ophthalmol 2004;88:1391-1394 (Pubitemid 39424716)
7. Reardon G, Schwartz GF, Mozaffari E. Patient persistency with pharmacotherapy in the management of glaucoma. Eur J Ophthalmol 2003;13(Suppl 4):S44-52.
8. Hodge WG, Lachaine J, Steffensen I, et al. The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: a systematic review. Br J Ophthalmol 2008;92:7-12.
9. Schuman JS, Horwitz B, Choplin NT, et al. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group. Arch Ophthalmol 1997;115:847-852
10. LeBlanc RP. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2. Ophthalmology 1998;105:1960-1967
11. Osborne SA, Montgomery DM, Morris D, et al. Alphagan allergy may increase the propensity for multiple eye-drop allergy. Eye 2005;19:129-137 (Pubitemid 40309497)
12. Lazaridou MN, Montgomery DM, Ho WO, et al. Changes in intraocular pressure following a switch from latanoprost monotherapy to latanoprost/timolol fixed combination therapy in patients with primary open-angle glaucoma or ocular hypertension: results from a clinical practice database. Curr Med Res Opin 2008;24:2724-2728